- Willow Biosciences (TSX:WLLW) has announced its financial results for its Q1 ended March 31, 2025, showcasing a significant turnaround in its financial performance
- The company reported a revenue of C$1.76 million, a substantial increase from C$0.051 million in the same period last year
- The company is undergoing a sweeping reorganization that includes the appointment of a new executive team and board of directors, as well as a rebranding initiative
- Willow Biosciences stock (TSX:WLLW) last traded at $0.03
Willow Biosciences (TSX:WLLW) has announced its financial results for its Q1 ended March 31, 2025, showcasing a significant turnaround in its financial performance. The company reported a revenue of C$1.76 million, a substantial increase from C$0.051 million in the same period last year. Net loss for the quarter was C$0.317 million, a marked improvement from the C$2.36 million loss reported a year ago.
This financial news follows last week’s statement of Willow’s C$30 million recapitalization financing plan. The company is undergoing a sweeping reorganization that includes the appointment of a new executive team and board of directors, as well as a rebranding initiative. Willow Biosciences will soon emerge as Atlas Energy Corp.
Following the reorganization, Atlas Energy will pivot its focus towards becoming an international upstream royalty and streaming company. The firm aims to build a diversified portfolio of oil and gas royalty and streaming assets, with a primary focus on international markets and selective opportunities in North America.
This news caused the company’s stock to rocket 200 per cent higher and it has risen 250 per cent since then.
This dramatic shift comes after Willow reported a net loss of C$6.1 million in 2024 and declared it would cease active operations. The reorganization and rebranding efforts are expected to position Atlas Energy Corp. for sustainable growth and profitability in the energy sector.
Willow Biosciences Inc. develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets.
Willow Biosciences stock (TSX:WLLW) last traded at $0.03.
Join the discussion: Find out what everybody’s saying about this stock on Willow Biosciences’ Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
